See All Slides - tctmd.com

Slides

Presentation TCT 2015

Can We Reduce Femoral Bailout Rates? Role of Ulnar Artery Access

Presenter: Olivier F. Bertrand, Sasko Kedev

October 15, 2015

Presentation TCT 2015

The XINSORB BRS: Differentiating Features and Clinical Update

Presenter: Alexandre Abizaid, Pieter C. Smits, Lei Ge

October 15, 2015

Presentation TCT 2015

CTA for Procedure Planning

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Jorge Gaspar

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Jay H Traverse

October 15, 2015

Presentation TCT 2015

Transcatheter Valve-in-Ring (Tricuspid Position)

Presenter: Rebecca T. Hahn, Joachim Schofer, Dominique Himbert

October 15, 2015

Presentation TCT 2015

Are All Metallic Stents Equal for LM Bifurcations?

Presenter: David E. Kandzari, Nicolas Foin

October 15, 2015

Presentation TCT 2015

Lepu NeoVas: Differentiating Features and Clinical Update

Presenter: Alexandre Abizaid, Pieter C. Smits, Yaling Han

October 15, 2015

Presentation TCT 2015

Paravalvular Regurgitation After TAVR 2: Importance of Valve Sizing and Calcium Patterns to Predict and Prevent Paravalvular Regurgitation After TAVR

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Jeffrey J. Popma

October 15, 2015

Presentation TCT 2015

The REG1 Anticoagulation System: Lessons From Factor IX Inhibitor Using RNA Aptamer Technology

Presenter: Carlo Briguori, Roxana Mehran

October 15, 2015

Presentation TCT 2015

Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

Presenter: John D. Carroll, Ioanna Kosmidou, Tomohiko Taniguchi

October 15, 2015

Advertisement

Slides

Can We Reduce Femoral Bailout Rates? Role of Ulnar Artery Access

The XINSORB BRS: Differentiating Features and Clinical Update

CTA for Procedure Planning

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

Transcatheter Valve-in-Ring (Tricuspid Position)

Are All Metallic Stents Equal for LM Bifurcations?

Lepu NeoVas: Differentiating Features and Clinical Update

Paravalvular Regurgitation After TAVR 2: Importance of Valve Sizing and Calcium Patterns to Predict and Prevent Paravalvular Regurgitation After TAVR

The REG1 Anticoagulation System: Lessons From Factor IX Inhibitor Using RNA Aptamer Technology

Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content